Recent advances in the production of recombinant subunit vaccines in Pichia pastoris

References

• Balamurugan V, Venkatesan G, Sen A, Annamalai L, Bhanuprakash V, Singh RK. Recombinant protein-based viral disease diagnostics in veterinary medicine. Expert Rev Mol Diagn 2010; 10:731-53; PMID:20843198; http://dx.doi.org/10.1586/erm.10.61
   PubMed Web of Science ®Google Scholar
• Ergun BG, Calik P. Lignocellulose degrading extremozymes produced by Pichia pastoris: current status and future prospects. Bio Process Biosyst Eng 2016; 39:1-36; PMID:26497303; http://dx.doi.org/10.1007/s00449-015-1476-6
   PubMed Web of Science ®Google Scholar
• Liu Y, Wu C, Wang J, Mo W, Yu M. Codon optimization, expression, purification, and functional characterization of recombinant human IL-25 in Pichia pastoris. Appl Microbiol Bio Technol 2013; 97:10349-58; http://dx.doi.org/10.1007/s00253-013-5264-4
   PubMed Web of Science ®Google Scholar
• Maccani A, Landes N, Stadlmayr G, Maresch D, Leitner C, Maurer M, Gasser B, Ernst W, Kunert R, Mattanovich D. Pichia pastoris secretes recombinant proteins less efficiently than Chinese hamster ovary cells but allows higher space-time yields for less complex proteins. Bio Technol J 2014; 9:526-37
   Google Scholar
• Schiller JT, Lowy DR. Raising expectations for subunit vaccine. J Infect Dis 2015; 211:1373-5; PMID:25420478; http://dx.doi.org/10.1093/infdis/jiu648
   PubMed Web of Science ®Google Scholar
• Wan SW, Lin CF, Wang S, Chen YH, Yeh TM, Liu HS, Anderson R, Lin YS. Current progress in dengue vaccines. J Biomed Sci 2013; 20:37; PMID:23758699; http://dx.doi.org/10.1186/1423-0127-20-37
   PubMed Web of Science ®Google Scholar
• Liljeqvist S, Stahl S. Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines. J Biotechnol 1999; 73:1-33; PMID:10483112; http://dx.doi.org/10.1016/S0168-1656(99)00107-8
   PubMed Web of Science ®Google Scholar
• Coffman RL, Sher A, Seder RA. Vaccine adjuvants: putting innate immunity to work. Immunity 2010; 33:492-503; PMID:21029960; http://dx.doi.org/10.1016/j.immuni.2010.10.002
   PubMed Web of Science ®Google Scholar
• Lieberman MM, Clements DE, Ogata S, Wang G, Corpuz G, Wong T, Martyak T, Gilson L, Coller BA, Leung J, et al. Preparation and immunogenic properties of a recombinant West Nile subunit vaccine. Vaccine 2007; 25:414-23; PMID:16996661; http://dx.doi.org/10.1016/j.vaccine.2006.08.018
   PubMed Web of Science ®Google Scholar
• Bill RM. Recombinant protein subunit vaccine synthesis in microbes: a role for yeast? J Pharm Pharmacol 2015; 67:319-28; PMID:25556638; http://dx.doi.org/10.1111/jphp.12353
   PubMed Web of Science ®Google Scholar
• Hu F, Li X, Lu J, Mao PH, Jin X, Rao B, et al. A visual method for direct selection of high-producing Pichia pastoris clones. BMC Biotechnol 2011; 11:23; PMID:21418613; http://dx.doi.org/10.1186/1472-6750-11-23
   PubMed Web of Science ®Google Scholar
• Spohner SC, Muller H, Quitmann H, Czermak P. Expression of enzymes for the usage in food and feed industry with Pichia pastoris. J Biotechnol 2015; 202:118-34; PMID:25687104; http://dx.doi.org/10.1016/j.jbiotec.2015.01.027
   PubMed Web of Science ®Google Scholar
• Weinacker D, Rabert C, Zepeda AB, Figueroa CA, Pessoa A, Farias JG. Applications of recombinant Pichia pastoris in the healthcare industry. Braz J Microbiol 2013; 44:1043-8; PMID:24688491; http://dx.doi.org/10.1590/S1517-83822013000400004
   PubMed Web of Science ®Google Scholar
• Celik E, Calik P. Production of recombinant proteins by yeast cells. Bio Technol Adv 2012; 30:1108-18; PMID:21964262; http://dx.doi.org/10.1016/j.biotechadv.2011.09.011
   PubMed Web of Science ®Google Scholar
• Krainer FW, Dietzsch C, Hajek T, Herwig C, Spadiut O, Glieder A. Recombinant protein expression in Pichia pastoris strains with an engineered methanol utilization pathway. Microb Cell Fact 2012; 11:22; PMID:22330134; http://dx.doi.org/10.1186/1475-2859-11-22
   PubMed Web of Science ®Google Scholar
• Cos O, Ramon R, Montesinos JL, Valero F. Operational strategies, monitoring and control of heterologous protein production in the methylotrophic yeast Pichia pastoris under different promoters: a review. Microb Cell Fact 2006; 5:17; PMID:16600031; http://dx.doi.org/10.1186/1475-2859-5-17
   PubMed Web of Science ®Google Scholar
• Kim SJ, Lee JA, Kim YH, Song BK. Optimization of the functional expression of Coprinus cinereus peroxidase in Pichia pastoris by varying the host and promoter. J Microbiol Biotechnol 2009; 19:966-71; PMID:19809254; http://dx.doi.org/10.4014/jmb.0901.018
   PubMed Web of Science ®Google Scholar
• Cereghino JL, Cregg JM. Heterologous protein expression in the methylotrophic yeast Pichia pastoris. FEMS Microbiol Rev 2000; 24:45-66; PMID:10640598; http://dx.doi.org/10.1111/j.1574-6976.2000.tb00532.x
   PubMed Web of Science ®Google Scholar
• Byrne B. Pichia pastoris as an expression host for membrane protein structural biology. Curr Opin Struct Biol 2015; 32:9-17; PMID:25658849; http://dx.doi.org/10.1016/j.sbi.2015.01.005
   PubMed Web of Science ®Google Scholar
• Wang X, Wang Q, Wang J, Bai P, Shi L, Shen W, Zhou M, Zhou X, Zhang Y, Cai M. Mit1 Transcription Factor Mediates Methanol Signaling and Regulates the Alcohol Oxidase 1 (AOX1) Promoter in Pichia pastoris. J Biol Chem 2016; 291:6245-61; PMID:26828066; http://dx.doi.org/10.1074/jbc.M115.692053
   PubMed Web of Science ®Google Scholar
• Ahmad M, Hirz M, Pichler H, Schwab H. Protein expression in Pichia pastoris: recent achievements and perspectives for heterologous protein production. Appl Microbiol Biotechnol 2014; 98:5301-17; PMID:24743983; http://dx.doi.org/10.1007/s00253-014-5732-5
   PubMed Web of Science ®Google Scholar
• Prielhofer R, Maurer M, Klein J, Wenger J, Kiziak C, Gasser B, Mattanovich D. Induction without methanol: novel regulated promoters enable high-level expression in Pichia pastoris. Microb Cell Fact 2013; 12:5; PMID:23347568; http://dx.doi.org/10.1186/1475-2859-12-5
   PubMed Web of Science ®Google Scholar
• Shen S, Sulter G, Jeffries TW, Cregg JM. A strong nitrogen source-regulated promoter for controlled expression of foreign genes in the yeast Pichia pastoris. Gene 1998; 216:93-102; PMID:9714758; http://dx.doi.org/10.1016/S0378-1119(98)00315-1
   PubMed Web of Science ®Google Scholar
• Resina D, Serrano A, Valero F, Ferrer P. Expression of a Rhizopus oryzae lipase in Pichia pastoris under control of the nitrogen source-regulated formaldehyde dehydrogenase promoter. J Biotechnol 2004; 109:103-13; PMID:15063618; http://dx.doi.org/10.1016/j.jbiotec.2003.10.029
   PubMed Web of Science ®Google Scholar
• Waterham HR, Digan ME, Koutz PJ, Lair SV, Cregg JM. Isolation of the Pichia pastoris glyceraldehyde-3-phosphate dehydrogenase gene and regulation and use of its promoter. Gene 1997; 186:37-44; PMID:9047342; http://dx.doi.org/10.1016/S0378-1119(96)00675-0
   PubMed Web of Science ®Google Scholar
• de Almeida JR, de Moraes LM, Torres FA. Molecular characterization of the 3-phosphoglycerate kinase gene (PGK1) from the methylotrophic yeast Pichia pastoris. Yeast 2005; 22:725-37; PMID:16034819; http://dx.doi.org/10.1002/yea.1243
   PubMed Web of Science ®Google Scholar
• Ahn J, Hong J, Lee H, Park M, Lee E, Kim C, Choi E, Jung J, Lee H. Translation elongation factor 1-α gene from Pichia pastoris: molecular cloning, sequence, and use of its promoter. Appl Microbiol Biotechnol 2007; 74:601-8; PMID:17124582; http://dx.doi.org/10.1007/s00253-006-0698-6
   PubMed Web of Science ®Google Scholar
• Damasceno LM, Huang CJ, Batt CA. Protein secretion in Pichia pastoris and advances in protein production. Appl Microbiol Biotechnol 2012; 93:31-9; PMID:22057543; http://dx.doi.org/10.1007/s00253-011-3654-z
   PubMed Web of Science ®Google Scholar
• Andre N, Cherouati N, Prual C, Steffan T, Zeder-Lutz G, Magnin T, Pattus F, Michel H, Wagner R, Reinhart C. Enhancing functional production of G protein-coupled receptors in Pichia pastoris to levels required for structural studies via a single expression screen. Protein Sci 2006; 15:1115-26; PMID:16597836; http://dx.doi.org/10.1110/ps.062098206
   PubMed Web of Science ®Google Scholar
• Abad S, Kitz K, Hormann A, Schreiner U, Hartner FS, Glieder A. Real-time PCR-based determination of gene copy numbers in Pichia pastoris. Bio Technol J 2010; 5:413-20
   Google Scholar
• Vogl T, Hartner FS, Glieder A. New opportunities by synthetic biology for biopharmaceutical production in Pichia pastoris. Curr Opin Bio Technol 2013; 24:1094-101; http://dx.doi.org/10.1016/j.copbio.2013.02.024
   PubMed Web of Science ®Google Scholar
• Demain AL, Vaishnav P. Production of recombinant proteins by microbes and higher organisms. Bio Technol Adv 2009; 27:297-306
   Google Scholar
• De Schutter K, Lin YC, Tiels P, Van Hecke A, Glinka S, Weber-Lehmann J, Rouzé P, Van de Peer Y, Callewaert N. Genome sequence of the recombinant protein production host Pichia pastoris. Nat Bio Technol 2009; 27:561-6; http://dx.doi.org/10.1038/nbt.1544
   PubMed Web of Science ®Google Scholar
• Roongsawang N, Puseenam A, Kitikhun S, Sae-Tang K, Harnpicharnchai P, Ohashi T, Fujiyama K, Tirasophon W, Tanapongpipat S. A novel potential signal peptide sequence and overexpression of ER-Resident chaperones enhance heterologous protein secretion in thermotolerant methylotrophic yeast ogataea thermomethanolica. Appl Biochem Biotechnol 2016; 178:710-24; PMID:26519344; http://dx.doi.org/10.1007/s12010-015-1904-8
   PubMed Web of Science ®Google Scholar
• Zhang Y, Teng D, Mao R, Wang X, Xi D, Hu X, Wang J. High expression of a plectasin-derived peptide NZ2114 in Pichia pastoris and its pharmacodynamics, postantibiotic and synergy against Staphylococcus aureus. Appl Microbiol Biotechnol 2014; 98:681-94; PMID:23624708
   PubMed Web of Science ®Google Scholar
• Kaufmann SH, Hussey G, Lambert PH. New vaccines for tuberculosis. Lancet 2010; 375:2110-9; PMID:20488515; http://dx.doi.org/10.1016/S0140-6736(10)60393-5
   PubMed Web of Science ®Google Scholar
• Waheed MT, Sameeullah M, Khan FA, Syed T, Ilahi M, Gottschamel J, Lössl AG. Need of cost-effective vaccines in developing countries: What plant biotechnology can offer? Springerplus 2016; 5:65; PMID:26839758; http://dx.doi.org/10.1186/s40064-016-1713-8
   PubMed Web of Science ®Google Scholar
• Plotkin SA. Vaccines: past, present and future. Nat Med 2005; 11:S5-11; PMID:15812490; http://dx.doi.org/10.1038/nm1209
   PubMed Web of Science ®Google Scholar
• Bill RM. Playing catch-up with Escherichia coli: using yeast to increase success rates in recombinant protein production experiments. Front Microbiol 2014; 5:85; PMID:24634668; http://dx.doi.org/10.3389/fmicb.2014.00085
   PubMed Web of Science ®Google Scholar
• Zhang N, Jiang S, Du L. Current advancements and potential strategies in the development of MERS-CoV vaccines. Expert Rev Vaccines 2014; 13:761-74; PMID:24766432; http://dx.doi.org/10.1586/14760584.2014.912134
   PubMed Web of Science ®Google Scholar
• Oyston P, Robinson K. The current challenges for vaccine development. J Med Microbiol 2012; 61:889-94; PMID:22322337; http://dx.doi.org/10.1099/jmm.0.039180-0
   PubMed Web of Science ®Google Scholar
• Moyle PM, Toth I. Modern subunit vaccines: development, components, and research opportunities. ChemMedChem 2013; 8:360-76; PMID:23316023; http://dx.doi.org/10.1002/cmdc.201200487
   PubMed Web of Science ®Google Scholar
• Pulendran B, Ahmed R. Immunological mechanisms of vaccination. Nat Immunol 2011; 12:509-17; PMID:21739679; http://dx.doi.org/10.1038/ni.2039
   PubMed Web of Science ®Google Scholar
• Black M, Trent A, Tirrell M, Olive C. Advances in the design and delivery of peptide subunit vaccines with a focus on toll-like receptor agonists. Expert Rev Vaccines 2010; 9:157-73; PMID:20109027; http://dx.doi.org/10.1586/erv.09.160
   PubMed Web of Science ®Google Scholar
• Trumpfheller C, Longhi MP, Caskey M, Idoyaga J, Bozzacco L, Keler T, Schlesinger SJ, Steinman RM. Dendritic cell-targeted protein vaccines: a novel approach to induce T-cell immunity. J Intern Med 2012; 271:183-92; PMID:22126373; http://dx.doi.org/10.1111/j.1365-2796.2011.02496.x
   PubMed Web of Science ®Google Scholar
• Cox MM. Recombinant protein vaccines produced in insect cells. Vaccine 2012; 30:1759-66; PMID:22265860; http://dx.doi.org/10.1016/j.vaccine.2012.01.016
   PubMed Web of Science ®Google Scholar
• Roldao A, Mellado MC, Castilho LR, Carrondo MJ, Alves PM. Virus-like particles in vaccine development. Expert Rev Vaccines 2010; 9:1149-76; PMID:20923267; http://dx.doi.org/10.1586/erv.10.115
   PubMed Web of Science ®Google Scholar
• Yamaji H, Konishi E. Production of Japanese encephalitis virus-like particles in insect cells. Bio Engineered 2013; 4:438-42
   Google Scholar
• Dong H, Guo HC, Sun SQ. Virus-like particles in picornavirus vaccine development. Appl Microbiol Bio Technol 2014; 98:4321-9; PMID:24647496; http://dx.doi.org/10.1007/s00253-014-5639-1
   PubMed Web of Science ®Google Scholar
• Chackerian B, Lenz P, Lowy DR, Schiller JT. Determinants of autoantibody induction by conjugated papillomavirus virus-like particles. J Immunol 2002; 169:6120-6; PMID:12444114; http://dx.doi.org/10.4049/jimmunol.169.11.6120
   PubMed Web of Science ®Google Scholar
• Keating GM, Noble S. Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B. Drugs 2003; 63:1021-51; PMID:12699402; http://dx.doi.org/10.2165/00003495-200363100-00006
   PubMed Web of Science ®Google Scholar
• Bryan JT, Buckland B, Hammond J, Jansen KU. Prevention of cervical cancer: journey to develop the first human papillomavirus virus-like particle vaccine and the next generation vaccine. Curr Opin Chem Biol 2016; 32:34-47; PMID:26994695; http://dx.doi.org/10.1016/j.cbpa.2016.03.001
   PubMed Web of Science ®Google Scholar
• Chroboczek J, Szurgot I, Szolajska E. Virus-like particles as vaccine. Acta Biochim Pol 2014; 61:531-9; PMID:25273564
   PubMed Web of Science ®Google Scholar
• Bohles N, Busch K, Hensel M. Vaccines against human diarrheal pathogens: current status and perspectives. Hum Vaccin Immunother 2014; 10:1522-35; PMID:24861668; http://dx.doi.org/10.4161/hv.29241
   PubMed Web of Science ®Google Scholar
• Foged C. Subunit vaccines of the future: the need for safe, customized and optimized particulate delivery systems. Ther Deliv 2011; 2:1057-77; PMID:22826868; http://dx.doi.org/10.4155/tde.11.68
   PubMedGoogle Scholar
• Greek R, Menache A. Systematic reviews of animal models: methodology versus epistemology. Int J Med Sci 2013; 10:206-21; PMID:23372426; http://dx.doi.org/10.7150/ijms.5529
   PubMed Web of Science ®Google Scholar
• Bodewes R, Rimmelzwaan GF, Osterhaus AD. Animal models for the preclinical evaluation of candidate influenza vaccines. Expert Rev Vaccines 2010; 9:59-72; PMID:20021306; http://dx.doi.org/10.1586/erv.09.148
   PubMed Web of Science ®Google Scholar
• Jackson LA, Gaglani MJ, Keyserling HL, Balser J, Bouveret N, Fries L, Treanor JJ. Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons. BMC Infect Dis 2010; 10:71; PMID:20236548; http://dx.doi.org/10.1186/1471-2334-10-71
   PubMed Web of Science ®Google Scholar
• Ferrer-Miralles N, Domingo-Espin J, Corchero JL, Vazquez E, Villaverde A. Microbial factories for recombinant pharmaceuticals. Microb Cell Fact 2009; 8:17; PMID:19317892; http://dx.doi.org/10.1186/1475-2859-8-17
   PubMed Web of Science ®Google Scholar
• Mattanovich D, Branduardi P, Dato L, Gasser B, Sauer M, Porro D. Recombinant protein production in yeasts. Methods Mol Biol 2012; 824:329-58; PMID:22160907; http://dx.doi.org/10.1007/978-1-61779-433-9_17
   PubMedGoogle Scholar
• Sorensen HP. Towards universal systems for recombinant gene expression. Microb Cell Fact 2010; 9:27; PMID:20433754; http://dx.doi.org/10.1186/1475-2859-9-27
   PubMed Web of Science ®Google Scholar
• Rickinson AB. Co-infections, inflammation and oncogenesis: future directions for EBV research. Semin Cancer Biol 2014; 26:99-115; PMID:24751797; http://dx.doi.org/10.1016/j.semcancer.2014.04.004
   PubMed Web of Science ®Google Scholar
• Wang M, Jiang S, Han Z, Zhao B, Wang L, Zhou Z, Wang Y. Expression and immunogenic characterization of recombinant gp350 for developing a subunit vaccine against Epstein-Barr virus. Appl Microbiol Biotechnol 2016; 100:1221-30; PMID:26433969; http://dx.doi.org/10.1007/s00253-015-7027-x
   PubMed Web of Science ®Google Scholar
• Kato K, Sano H, Nagata K, Sugihara H, Kanai K, Kuwamoto S, et al. Synthetic peptides of Epstein-Barr virus-major envelope glycoprotein-350/220 do not prevent infection in a rabbit Epstein-Barr virus infection model. J Vaccines Vaccin 2012; 3:148; http://dx.doi.org/10.4172/2157-7560.1000150
   Google Scholar
• Wang M, Jiang S, Liu X, Wang Y. Expression, purification, and immunogenic characterization of Epstein-Barr virus recombinant EBNA1 protein in Pichia pastoris. Appl Microbiol Biotechnol 2013; 97:6251-62; PMID:23685476; http://dx.doi.org/10.1007/s00253-013-4967-x
   PubMed Web of Science ®Google Scholar
• Mayer CE, Geerlof A, Schepers A. Efficient expression and purification of tag-free Epstein-Barr virus EBNA1 protein in Escherichia coli by auto-induction. Protein Expr Purif 2012; 86:7-11; PMID:22944205; http://dx.doi.org/10.1016/j.pep.2012.08.010
   PubMed Web of Science ®Google Scholar
• Wallace D, Canouet V, Garbes P, Wartel TA. Challenges in the clinical development of a dengue vaccine. Curr Opin Virol 2013; 3:352-6; PMID:23747120; http://dx.doi.org/10.1016/j.coviro.2013.05.014
   PubMed Web of Science ®Google Scholar
• Kaushik N, Rohila D, Arora U, Raut R, Lamminmaki U, Khanna N, Batra G. Casamino acids facilitate the secretion of recombinant dengue virus serotype-3 envelope domain III in Pichia pastoris. BMC Biotechnol 2016; 16:12; PMID:26847361; http://dx.doi.org/10.1186/s12896-016-0243-3
   PubMed Web of Science ®Google Scholar
• Peiris JS, de Jong MD, Guan Y. Avian influenza virus (H5N1): a threat to human health. Clin Microbiol Rev 2007; 20:243-67; PMID:17428885; http://dx.doi.org/10.1128/CMR.00037-06
   PubMed Web of Science ®Google Scholar
• Subathra M, Santhakumar P, Narasu ML, Beevi SS, Lal SK. Evaluation of antibody response in mice against avian influenza A (H5N1) strain neuraminidase expressed in yeast Pichia pastoris. J Biosci 2014; 39:443-51; PMID:24845508; http://dx.doi.org/10.1007/s12038-014-9422-3
   PubMed Web of Science ®Google Scholar
• Kwon WT, Lee WS, Park PJ, Park TK, Kang H. Protective immunity of Pichia pastoris-expressed recombinant envelope protein of Japanese encephalitis virus. J Microbiol Biotechnol 2012; 22:1580-7; PMID:23124351; http://dx.doi.org/10.4014/jmb.1205.05047
   PubMed Web of Science ®Google Scholar
• Liang Z, Wang J. EV71 vaccine, an invaluable gift for children. Clin Transl Immunol 2014; 3:e28; http://dx.doi.org/10.1038/cti.2014.24
   PubMedGoogle Scholar
• Wang M, Jiang S, Wang Y. Recombinant VP1 protein expressed in Pichia pastoris induces protective immune responses against EV71 in mice. Biochem Biophys Res Commun 2013; 430:387-93; PMID:23159634; http://dx.doi.org/10.1016/j.bbrc.2012.11.035
   PubMed Web of Science ®Google Scholar
• Tripathi L, Mani S, Raut R, Poddar A, Tyagi P, Arora U, de Silva A, Swaminathan S, Khanna N. Pichia pastoris-expressed dengue 3 envelope-based virus-like particles elicit predominantly domain III-focused high titer neutralizing antibodies. Front Microbiol 2015; 6:1005; PMID:26441930; http://dx.doi.org/10.3389/fmicb.2015.01005
   PubMed Web of Science ®Google Scholar
• Lowy DR. HPV vaccination to prevent cervical cancer and other HPV-associated disease: from basic science to effective interventions. J Clin Invest 2016; 126:5-11; PMID:26727228; http://dx.doi.org/10.1172/JCI85446
   PubMed Web of Science ®Google Scholar
• Bazan SB, de Alencar Muniz Chaves A, Aires KA, Cianciarullo AM, Garcea RL, Ho PL. Expression and characterization of HPV-16 L1 capsid protein in Pichia pastoris. Arch Virol 2009; 154:1609-17; PMID:19756360; http://dx.doi.org/10.1007/s00705-009-0484-8
   PubMed Web of Science ®Google Scholar
• Mariz FC, Coimbra EC, Jesus AL, Nascimento LM, Torres FA, Freitas AC. Development of an IP-Free biotechnology platform for constitutive production of HPV16 L1 capsid protein using the pichia pastoris PGK1 promoter. Biomed Res Int 2015; 2015:594120; PMID:26090426; http://dx.doi.org/10.1155/2015/594120
   PubMed Web of Science ®Google Scholar
• Huang X, Wei H, Wu S, Du Y, Liu L, Su J, Xu Y, Wang H, Li X, Wang Y, et al. Epidemiological and etiological characteristics of hand, foot, and mouth disease in Henan, China, 2008-2013. Sci Rep 2015; 5:8904; PMID:25754970; http://dx.doi.org/10.1038/srep08904
   PubMed Web of Science ®Google Scholar
• Zhang C, Liu Q, Ku Z, Hu Y, Ye X, Zhang Y, Huang Z. Coxsackievirus A16-like particles produced in Pichia pastoris elicit high-titer neutralizing antibodies and confer protection against lethal viral challenge in mice. Antiviral Res 2016; 129:47-51; PMID:26902108; http://dx.doi.org/10.1016/j.antiviral.2016.02.011
   PubMed Web of Science ®Google Scholar
• Zhang C, Ku Z, Liu Q, Wang X, Chen T, Ye X, Li D, Jin X, Huang Z. High-yield production of recombinant virus-like particles of enterovirus 71 in Pichia pastoris and their protective efficacy against oral viral challenge in mice. Vaccine 2015; 33:2335-41; PMID:25820068; http://dx.doi.org/10.1016/j.vaccine.2015.03.034
   PubMed Web of Science ®Google Scholar
• Gurramkonda C, Zahid M, Nemani SK, Adnan A, Gudi SK, Khanna N, Ebensen T, Lünsdorf H, Guzmán CA, Rinas U. Purification of hepatitis B surface antigen virus-like particles from recombinant Pichia pastoris and in vivo analysis of their immunogenic properties. J Chromatogr B Analyt Technol Biomed Life Sci 2013; 940:104-11; PMID:24141044; http://dx.doi.org/10.1016/j.jchromb.2013.09.030
   PubMed Web of Science ®Google Scholar
• Liu L, Yang H, Shin HD, Chen RR, Li J, Du G, Chen J. How to achieve high-level expression of microbial enzymes: strategies and perspectives. Bio Engineered 2013; 4:212-23; PMID:23686280; http://dx.doi.org/10.4161/bioe.24761
   PubMed Web of Science ®Google Scholar
• Li Z, Hong G, Wu Z, Hu B, Xu J, Li L. Optimization of the expression of hepatitis B virus e gene in Pichia pastoris and immunological characterization of the product. J Biotechnol 2008; 138:1-8; PMID:18721834; http://dx.doi.org/10.1016/j.jbiotec.2008.07.1989
   PubMed Web of Science ®Google Scholar
• Athmaram TN, Saraswat S, Singh AK, Rao MK, Gopalan N, Suryanarayana VV, Rao PV. Influence of copy number on the expression levels of pandemic influenza hemagglutinin recombinant protein in methylotrophic yeast Pichia pastoris. Virus Genes 2012; 45:440-51; PMID:22940846; http://dx.doi.org/10.1007/s11262-012-0809-7
   PubMed Web of Science ®Google Scholar
• Yu P, Zhu Q, Chen K, Lv X. Improving the secretory production of the heterologous protein in Pichia pastoris by focusing on protein folding. Appl Bio Chem Bio Technol 2015; 175:535-48
   Google Scholar
• Ben Azoun S, Belhaj AE, Gongrich R, Gasser B, Kallel H. Molecular optimization of rabies virus glycoprotein expression in Pichia pastoris. Microb Bio Technol 2016; 9:355-68
   Google Scholar
• Ebrahimi SM, Tebianian M, Toghyani H, Memarnejadian A, Attaran HR. Cloning, expression and purification of the influenza A (H9N2) virus M2e antigen and truncated Mycobacterium tuberculosis HSP70 as a fusion protein in Pichia pastoris. Protein Expr Purif 2010; 70:7-12; PMID:19897044; http://dx.doi.org/10.1016/j.pep.2009.11.001
   PubMed Web of Science ®Google Scholar
• Li X, Luo J, Wang S, Shen Y, Qiu Y, Wang X, Deng X, Liu X, Bao W, Liu P, et al. Engineering, expression, and immuno-characterization of recombinant protein comprising multi-neutralization sites of rabies virus glycoprotein. Protein Expr Purif 2010; 70:179-83; PMID:19755161; http://dx.doi.org/10.1016/j.pep.2009.09.005
   PubMed Web of Science ®Google Scholar
• Gasser B, Saloheimo M, Rinas U, Dragosits M, Rodriguez-Carmona E, Baumann K, Giuliani M, Parrilli E, Branduardi P, Lang C, et al. Protein folding and conformational stress in microbial cells producing recombinant proteins: a host comparative overview. Microb Cell Fact 2008; 7:11; PMID:18394160; http://dx.doi.org/10.1186/1475-2859-7-11
   PubMed Web of Science ®Google Scholar
• Delic M, Graf AB, Koellensperger G, Haberhauer-Troyer C, Hann S, Mattanovich D, et al. Overexpression of the transcription factor Yap1 modifies intracellular redox conditions and enhances recombinant protein secretion. Microbial Cell 2014; 1:376-86; http://dx.doi.org/10.15698/mic2014.11.173
   PubMedGoogle Scholar
• Delic M, Rebnegger C, Wanka F, Puxbaum V, Haberhauer-Troyer C, Hann S, Köllensperger G, Mattanovich D, Gasser B. Oxidative protein folding and unfolded protein response elicit differing redox regulation in endoplasmic reticulum and cytosol of yeast. Free Radic Biol Med 2012; 52:2000-12; PMID:22406321; http://dx.doi.org/10.1016/j.freeradbiomed.2012.02.048
   PubMed Web of Science ®Google Scholar
• Idiris A, Tohda H, Kumagai H, Takegawa K. Engineering of protein secretion in yeast: strategies and impact on protein production. Appl Micro Biol Bio Technol 2010; 86:403-17; http://dx.doi.org/10.1007/s00253-010-2447-0
   PubMed Web of Science ®Google Scholar
• Macauley-Patrick S, Fazenda ML, McNeil B, Harvey LM. Heterologous protein production using the Pichia pastoris expression system. Yeast 2005; 22:249-70; PMID:15704221; http://dx.doi.org/10.1002/yea.1208
   PubMed Web of Science ®Google Scholar
• Yang S, Kuang Y, Li H, Liu Y, Hui X, Li P, Jiang Z, Zhou Y, Wang Y, Xu A, et al. Enhanced production of recombinant secretory proteins in Pichia pastoris by optimizing Kex2 P1' site. PLoS One 2013; 8:e75347; PMID:24069404; http://dx.doi.org/10.1371/journal.pone.0075347
   PubMed Web of Science ®Google Scholar
• Gasser B, Prielhofer R, Marx H, Maurer M, Nocon J, Steiger M, Puxbaum V, Sauer M, Mattanovich D. Pichia pastoris: protein production host and model organism for biomedical research. Future Microbiol 2013; 8:191-208; PMID:23374125; http://dx.doi.org/10.2217/fmb.12.133
   PubMed Web of Science ®Google Scholar
• Jacobs PP, Geysens S, Vervecken W, Contreras R, Callewaert N. Engineering complex-type N-glycosylation in Pichia pastoris using GlycoSwitch technology. Nat Protoc 2009; 4:58-70; PMID:19131957; http://dx.doi.org/10.1038/nprot.2008.213
   PubMed Web of Science ®Google Scholar
• Holmes WJ, Darby RA, Wilks MD, Smith R, Bill RM. Developing a scalable model of recombinant protein yield from Pichia pastoris: the influence of culture conditions, biomass and induction regime. Microb Cell Fact 2009; 8:35; PMID:19570229; http://dx.doi.org/10.1186/1475-2859-8-35
   PubMed Web of Science ®Google Scholar